Zoetis Inc - Class A

ZTS

$202.70

+28.3% last 12 months

Market Cap

$97.9 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$140.85 - $249.27

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

49.41x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$1.00 (0.48%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $97.9 Billion
Enterprise Value $101 Billion
Dividend Yield $1.00 (0.48%)
1 Year Return +28.8%
52-Week High $249.27
52-Week Low $140.85
Beta 0.9
Outstanding Shares 473 Million
Avg 30 Day Volume 2.05 Million

Valuation

P/E Ratio 49.41
PEG 324.23
Earnings per Share $4.15
Price to Sales Ratio 12.67
Price to Book Ratio 22.52
Revenue to Enterprise Value 13.3
EBIT to Enterprise Value 37.06
Total Debt to Enterprise Value 0.07
Debt to Equity 1.41

Profitability

Revenue $7.62 Billion
Gross Profit $5.31 Billion
EBIT $2.73 Billion
Net Income $1.98 Billion
Profit Margin 26.02%
Quarterly Earnings Growth (YoY) +15.2%
Return on Equity 42.36%
Return on Assets 14.46%
Return on Invested Capital 22.33%

Insider trades

No purchases

20,521 shares sold (2 transactions)

No purchases

8,342 shares sold (3 transactions)

No purchases

17,130 shares sold (4 transactions)

No purchases

No sells

Q2 2021 Q3 2021 Q4 2021 Q1 2022

About Zoetis Inc - Class A

CEO: Kristin Peck

Employees: 9,200

Industry: Pharmaceutical Preparation Manufacturing

Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees.

Similar stocks

Lilly(Eli) & Co
Lilly(Eli) & Co
Merck & Co Inc
Merck & Co Inc
Pfizer Inc.
Pfizer Inc.
Phibro Animal Health Corp. - Class A
Phibro Animal Health Corp. - Class A
Kindred Biosciences Inc
Kindred Biosciences Inc
Heska Corp. (Restricted Voting)
Heska Corp. (Restricted Voting)
Sanofi - ADR
Sanofi - ADR
Immucell Corp.
Immucell Corp.

News